CMS Adds Certain Surgical Dressings to DMEPOS Master List

CMS has added 2 categories of surgical dressings to its Master List of DMEPOS Items Potentially Subject to Conditions of Payment, effective October 28, 2026. While these products are not being added to the Required Prior Authorization List at this time, providers should understand what the designation means and continue to maintain thorough documentation.

Key Takeaways

• Two surgical dressing HCPCS codes have been added to the CMS DMEPOS Master List. Effective October 28, 2026, CMS added collagen dressings (A6022) and certain alginate or fiber gelling dressings (A6107) to the Master List of DMEPOS Items Potentially Subject to Conditions of Payment.
• No new prior authorization requirements are being implemented. Although items on the Master List may later be considered for inclusion on the Required Prior Authorization List, these surgical dressings are not being added to that list at this time, and no additional provider action is currently required.
• Documentation and compliance remain important. CMS identifies items on the Master List as potential sources of fraud or unnecessary utilization. Providers supplying these dressings should continue to follow Medicare and other payer documentation and compliance requirements to support appropriate coverage and payment.

On July 30, 2026, the Centers for Medicare and Medicaid Services (CMS) added certain surgical dressings to its "Master List of Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Items Potentially Subject to Conditions of Payment,” with an effective date of October 28, 2026.¹  

The items added to the Master List were¹:

• A6022 - Collagen dressing, sterile, size more than 16 sq. in. But less than or equal to 48 sq. in., each
• A6107 - Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. But less than or equal to 48 sq. in., each dressing

Medicare claims that items on this “Master List” are "a source of potential fraud or unnecessary utilization.”¹ Items on this Master List are candidates to be added to the CMS "Required Prior Authorization List.” At present, these items added to the Master List are not being added to the Required Prior Authorization List. Therefore, no additional action will be required for providers who supply these items. However, providers who supply these items should be aware that CMS states these items are "a source of potential fraud or unnecessary utilization.” As always, adherence to third party payer compliance and documentation guidelines is essential.

Reference 

1. Centers for Medicare & Medicaid Services. Master List of DMEPOS Items Potentially Subject to Conditions of Payment. Updated July 31, 2026. Accessed July 31, 2026. https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/medical-review-and-education/master-list-dmepos-items-potentially-subject-conditions-payment